Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticaloguard vs Brilique in Healthy Volunteers
NCT05474053Phase 3Completed
- Sponsor
- Cairo University
- Start
- Nov 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Cairo University. Started Nov 2021; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT05474053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05474053.